Investigators sought to determine the prevalence of small intestinal bacterial overgrowth and establish its prognostic value in patients with heart failure.
POCUS suggested in addition to standard diagnostic pathway for patients with acute dyspnea in ED, inpatient setting when diagnosis is uncertain
Patient-reported outcomes are a more sensitive measure than NYHA functional class for assessing changes in health status in HFrEF.
Consideration should be given to addition of meds for adults not meeting BP goals after 6 months of lifestyle therapy
Remote PAP-guided management better reduced PAP, hospitalizations, and mortality among patients with NYHA Class III HF.
Early detection of iron status may improve cardiovascular risk assessment in patients with CKD, according to investigators.
Primary effectiveness of no additional surgical or interventional procedures related to the device and acceptable heart blood flow function at 6 months, was achieved by 89.2%.
Women are at increased risk for heart failure, myocardial infarction, and stroke at lower levels of systolic blood pressure than men.
Bariatric surgery was found to be safe for patients with congestive heart failure.
Drinking coffee is linked to a lower risk of heart failure, challenging previous assumptions about caffeine consumption and heart health.
February is American Heart Month, and patients who have been diagnosed with cancer are part of a group that is uniquely vulnerable to cardiovascular disease. What risk factors should these patients know about for fatal heart disease?
An NP-led effort to reduce all-cause readmissions for patients with HF emphasizes patient engagement and goal setting for self-care.
January 2021 FDA approvals of import to physician assistants and nurse practitioners include treatments for HIV, heart failure, dry eye disease, and light chain amyloidosis.
Researchers analyzed a hypothyroidism comorbidity network for positive and negative associations with other chronic conditions.
In the 8 weeks following the first reported UK death due to COVID-19, there was a decrease in referral of patients with acute heart failure.
The sNDA is supported by data from the phase 3 EMPEROR-Reduced trial which compared the efficacy and safety of empagliflozin to placebo, in addition to recommended therapy, in 3730 patients with chronic heart failure with reduced ejection fraction.
Cross-sectional data from the National Health and Nutrition Examination Survey from 1988 to 1994 and 1999 to 2016 were used for this analysis.
Women are at increased risk for heart failure and death after first-time myocardial infarction.
Higher serum levels of VCAM-1 may be associated with incident HFpEF.
An intensive lifestyle intervention was found to be associated with a significant loss of fat mass and lean mass in adults with type 2 diabetes.